Empagliflozin confers reno‐protection in acute myocardial infarction and type 2 diabetes mellitus

AIMS: Although the reno‐protective effects of sodium–glucose cotransporter 2 inhibitors are known in patients with heart failure or type 2 diabetes mellitus (T2DM), this effect has not been confirmed in patients with acute myocardial infarction (AMI). METHODS AND RESULTS: The prospective, multicentr...

Descripción completa

Detalles Bibliográficos
Autores principales: Mozawa, Kosuke, Kubota, Yoshiaki, Hoshika, Yu, Tara, Shuhei, Tokita, Yukichi, Yodogawa, Kenji, Iwasaki, Yu‐ki, Yamamoto, Takeshi, Takano, Hitoshi, Tsukada, Yayoi, Asai, Kuniya, Miyamoto, Masaaki, Miyauchi, Yasushi, Kodani, Eitaro, Maruyama, Mitsunori, Tanabe, Jun, Shimizu, Wataru
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8497324/
https://www.ncbi.nlm.nih.gov/pubmed/34235875
http://dx.doi.org/10.1002/ehf2.13509

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8497324/
https://www.ncbi.nlm.nih.gov/pubmed/34235875
http://dx.doi.org/10.1002/ehf2.13509

Ejemplares similares